First Time Loading...

Addex Therapeutics Ltd
SIX:ADXN

Watchlist Manager
Addex Therapeutics Ltd Logo
Addex Therapeutics Ltd
SIX:ADXN
Watchlist
Price: 0.0668 CHF -5.92% Market Closed
Updated: May 16, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

6.1m
-32%
Assets
Growth Rates:
1 Year
-50%
3 Years
-69%
5 Years
-
7 Years
-
10 Years
-
2.2m
-24%
Liabilities
Growth Rates:
1 Year
-49%
3 Years
-44%
5 Years
-
7 Years
-
10 Years
-
3.9m
-36%
Equity
Growth Rates:
1 Year
-50%
3 Years
-75%
5 Years
-
7 Years
-
10 Years
-

Balance Sheet Decomposition
Addex Therapeutics Ltd

6.1m
Assets
2.2m
Liabilities
6.1m
Assets
2.2m
Liabilities
Current Assets 5.7m
Cash & Short-Term Investments 4.8m
Receivables 373.4k
Other Current Assets 615.2k
Non-Current Assets 395.4k
PP&E 341.1k
Other Non-Current Assets 54.3k
Current Liabilities 1.9m
Accounts Payable 389.8k
Accrued Liabilities 1.3m
Other Current Liabilities 206.4k
Non-Current Liabilities 262.7k
Long-Term Debt 116.9k
Other Non-Current Liabilities 145.8k

Balance Sheet
Addex Therapeutics Ltd

Rotate your device to view
Balance Sheet
Currency: CHF
Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021
Assets
Cash & Cash Equivalents
15
3
2
3
1
3
42
32
19
20
Cash
0
0
2
3
1
3
42
27
0
0
Cash Equivalents
15
3
0
0
0
0
0
5
19
20
Total Receivables
1
1
0
0
0
0
0
0
0
0
Accounts Receivables
0
0
0
0
0
0
0
0
0
0
Other Receivables
0
0
0
0
0
0
0
0
0
0
Other Current Assets
1
0
0
0
0
0
0
1
1
1
Total Current Assets
17
4
2
3
2
3
42
32
19
22
PP&E Net
2
0
0
0
0
0
0
1
1
1
PP&E Gross
2
0
0
0
0
0
0
1
1
1
Accumulated Depreciation
19
21
4
3
3
3
3
3
3
4
Intangible Assets
0
0
0
0
0
0
0
0
0
0
Note Receivable
1
0
0
0
0
0
0
0
0
0
Long-Term Investments
1
1
0
0
0
0
0
0
0
0
Other Long-Term Assets
0
0
0
0
0
0
0
0
0
0
Total Assets
22
N/A
6
-73%
4
-32%
3
-28%
2
-42%
3
+82%
42
+1 278%
33
-22%
20
-39%
23
+12%
Liabilities
Accounts Payable
1
1
1
0
1
0
1
2
1
2
Accrued Liabilities
4
2
1
1
1
1
1
2
2
2
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
0
0
0
0
0
0
Other Current Liabilities
0
0
0
0
0
0
0
1
1
0
Total Current Liabilities
5
2
2
1
1
1
2
6
4
4
Long-Term Debt
0
0
0
0
0
0
0
0
0
0
Other Liabilities
1
1
0
0
0
0
1
2
2
1
Total Liabilities
5
N/A
3
-46%
2
-43%
1
-26%
1
+19%
2
+18%
3
+73%
8
+152%
6
-26%
6
+1%
Equity
Common Stock
9
10
10
11
12
13
29
33
33
49
Retained Earnings
250
267
268
271
274
277
276
294
305
316
Additional Paid In Capital
258
260
260
262
263
265
286
286
287
284
Total Equity
16
N/A
3
-82%
2
-22%
2
-29%
0
-87%
1
+514%
39
+2 823%
26
-35%
15
-43%
17
+16%
Total Liabilities & Equity
22
N/A
6
-73%
4
-32%
3
-28%
2
-42%
3
+82%
42
+1 278%
33
-22%
20
-39%
23
+12%
Shares Outstanding
Common Shares Outstanding
9
10
10
11
12
13
26
27
27
38

See Also

Summary
ADXN intrinsic value, competitors valuation, and company profile.
DCF Valuation
ADXN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ADXN stock valuation using valuation multiples.
Wall Street Estimates
ADXN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ADXN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 137,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.